EGF-related peptides in the pathophysiology of the mammary gland

Journal of Mammary Gland Biology and Neoplasia

Volumn 2, Issue 2, 1997, Pages 143-151

  Normanno, Nicola ^a   Ciardiello, Fortunato ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Autocrine growth; Growth factors; Mammary gland; Neoplastic transformation

Indexed keywords

EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL; BREAST; BREAST TUMOR; CELL TRANSFORMATION; EPITHELIUM CELL; FEMALE; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; UDDER;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0031107249     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026351730785     Document Type: Article

References (60)

1. D. S. Salomon, R. B. Dickson, N. Normanno, T. Saeki, N. Kim, N. Kenney, and F. Ciardiello (1992). Interaction of oncogenes and growth factors in colon and breast cancer. In D. A. Spandidos, (ed.), Current Perspectives on Molecular and Cellular Oncology. JAI Press LTD, London, pp. 211-261.
2. B. K. Vonderhaar (1987). Local effect of EGF, α-TGF and EGF-like growth factors on lobuloalveolar development of the mouse mammary gland in vivo. J. Cell. Physiol. 132:581-584.
3. N. Kenney, G. R. Johnson, M. P. Selvam, N. Kim, C. Qi, T. Saeki, R. Brandt, F. Ciardiello, M. Shoyab, G. D. Plowman, A. Day, D. S. Salomon, and N. Normanno (1993). Transforming growth factor alpha (TGFα) and amphiregulin (AR) as autocrine growth factors in nontransformed, immortalized 184A1N4 human mammary epithelial cells. Mol. Cell Diff. 1:163-184.
4. N. Normanno, C. Qi, W. J. Gullick, M. G. Persico, Y. Yarden, D. Wen, G. D. Plowman, N. Kenney, G. R. Johnson, N. Kim, R. Brandt, I. Martinez-Lacaci, R. B. Dickson, and D. S. Salomon (1993). Expression of amphiregulin, cripto-1, and heregulin α in human breast cancer cells. Int. J. Oncol. 2:903-911.
5. N. Normanno, N. Kim, D. Wen, K. Smith, A. L. Harris, G. D. Plowman, G. Colletta, F. Ciardiello, and D. S. Salomon (1995). Expression of messenger RNA for amphiregulin, heregulin and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas. Breast Cancer Res. Treat. 35:293-297.
6. F. Ciardiello, N. Kim, N. E. Hynes, R. Jaggi, S. M. S. Redmond, D. S. Liscia, B. Sanfilippo, G. Merlo, R. Callahan, W. Kidwell, and D. S. Salomon (1988). Induction of transforming growth factor α expression in mouse mammary epithelial cells after transformation with a point mutated c-Ha-ras protooncogene. Mol. Endocrinol. 2:1202-1216.
7. F. Ciardiello, M. L. McGeady, N. Kim, F. Basolo, N. E. Hynes, B. Langton, H. Yokozaki, T. Saeki, J. Elliott, H. Masui, J. Mendelsohn, H. Soule, J. Russo, and D. S. Salomon (1990). Transforming growth factor-α expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-α complementary DNA leads to transformation. Cell Growth Diff. 1:407-420.
8. N. Normanno, M. P. Selvam, C. Qi, T. Saeki, G. R. Johnson, N. Kim, F. Ciardiello, M. Shoyab, G. D. Plowman, G. J. Todaro, and D. S. Salomon (1994). Amphiregulin as an autocrine growth factor for c-Ha-ras and c-erbB-2 transformed human mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 91:2790-2794.
9. G. Mincione, C. Bianco, S. Kannan, G. Colletta, F. Ciardiello, M. B. Sliwkowski, Y. Yarden, N. Normanno, A. Pramaggiore, N. Kim, and D. S. Salomon (1996). Enhanced expression of heregulin in c-erbB-2 and c-Ha-ras transformed mouse and human mammary epithelial cells. J. Cell. Biochem. 60:437-446.
10. C. K. Osborne, B. Hamilton, O. Titus, and R. B. Livingston (1980). Epidermal growth factor stimulation of human breast cancer cells in culture. Cancer Res. 40:2361-2366.
11. E. M. Valverius, S. E. Bates, M. Stampfer, R. Clark, F. McCormick, D. S. Salomon, M. E. Lippman, and R. B. Dickson (1989). Transforming growth factor α production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells. Mol. Endocrinol. 3:203-214.
12. S. E. Bates, E. M. Valverius, B. W. Ennis, D. A. Bronzert, J. P. Sheridan, M. Stampfer, J. Mendelsohn, M. E. Lippman, and R. B. Dickson (1990). Expression of the TGF-α/EGF receptor pathway in normal human breast epithelial cells. Endocrinol. 126:596-607.
13. J. A. Zwiebel, M. Bano, E. Nexo, D. S. Salomon, and W. R. Kidwell (1986). Partial purification of transforming growth factors from human milk. Cancer Res. 46:933-939.
14. D. S. Liscia, G. Merlo, F. Ciardiello, N. Kim, G. Smith, R. Callahan, and D. S. Salomon (1990). Transforming growth factor-α messenger RNA localization in the developing adult rat and human mammary gland by in situ hybridization. Dev. Biol. 140:123-131.
15. C. F. Brown, C. T. Teng, B. T. Pentecost, and R. P. DiAugustine (1989). Epidermal growth factor precursor in mouse lactating mammary gland alveolar cells. Mol. Endocrinol. 3:1077-1083.
16. J. A. Smith, R. Barraclough, D. G. Fernig, and P. S. Rudland (1989). Identification of alpha transforming growth factor as a possible local trophic agent for the mammary gland. J. Cell. Physiol. 141:362-370.
17. N. Kenney, R.-P. Huang, G. R. Johnson, J.-X. Wu, D. Okamura, W. Matheny, E. Kordon, W. J. Gullick, G. Plowman, G. H. Smith, D. S. Salomon, and E. D. Adamson (1995). Detection and location of amphiregulin and cripto-1 expression in the developing postnatal mouse mammary gland. Mol. Reprod. Develop. 41:277-286.
18. S. Li, G. D. Plowman, S. D. Buckley, and G. D. Shipley (1992). Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells. J. Cell. Physiol. 153:103-111.
19. N. E. Hynes, D. Taverna, I. M. Harwerth, F. Ciardiello, D. S. Salomon, T. Yamamoto, and B. Groner (1990). Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the β-casein gene in mouse mammary epithelial cells. Mol. Cell. Biol. 10:4027-4034.
20. D. Taverna, B. Groner, and N. E. Hynes (1991). Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinct effects upon mouse mammary epithelial cell differentiation. Cell Growth Diff. 2:145-154.
21. B. Marte, M. Jeschke, D. Graus-Porta, D. Taverna, P. Hofer, B. Groner, Y. Yarden, and N. E. Hynes (1995). Neu differentiation factor-heregulin modulates growth and differentiation of HC11 mammary epithelial cells. Mol. Endocrinol. 9:14-23.
22. L. C. Murphy, H. Dotzlaw, M. S. J. Wong, T. Miller, B. Mrockowski, Y. Gong, and L. J. Murphy (1990). Epidermal growth factor: receptor and ligand expression in human breast cancer. Semin. Cancer Biol. 1:305-315.
23. H. Dotzlaw, T. Miller, J. Karvelas, and L. C. Murphy (1990). Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression. Cancer Res. 50:4204-4208.
24. Y. Umekita, N. Enokizono, Y. Sagara, K. Kuriwaki, T. Takasaki, A. Yoshida, and H. Yoshida (1992). Immunohistochemical studies on TGFα in human breast cancer: their relationship to estrogen receptor status, histological grade, mitogenic index and nodal status. Arch. Pathol. Hist. 420:345-351.
25. Y. Mizukami, A. Nonomura, M. Noguchi, T. Taniya, N. Koyasaki, Y. Saito, T. Hashimoto, F. Matsubara, and N. Yanagihara (1991). Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas. Anticancer Res. 11:1485-1494.
26. J. A. Zwiebel, M. R. Davis, E. Kohn, D. S. Salomon, and W. R. Kidwell (1982). Anchorage-independent growth-conferring factor production by rat mammary tumor cells. Cancer Res. 42:5117-5125.
27. S. C. Liu, B. Sanfilippo, I. Perroteau, R. Derynck, D. S. Salomon, and W. R. Kidwell (1987). Expression of transforming growth factor α (TGFα) in differentiated rat mammary tumors: estrogen induction of TGFα production. Mol. Endocrinol. 1:683-692.
28. D. S. Salomon, I. Perroteau, W. Kidwell, J. Tam, and R. Derynck (1987). Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells. J. Cell. Physiol. 130:397-409.
29. F. Ciardiello, N. E. Hynes, N. Kim, E. M. Valverius, M. E. Lippman, and D. S. Salomon (1989). Transformation of mouse mammary epithelial cells with the Ha-ras but not with the neu oncogene results in a gene dosage-dependent increase in transforming growth factor-α production. FEBS Lett. 250:474-478.
30. S. E. Bates, N. Davidson, E. M. Valverius, C. Freter, R. B. Dickson, J. Tam, J. Kudlow, M. E. Lippman, and D. S. Salomon (1988). Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol. Endocrinol. 2:543-555.
31. T. Saeki, A. Cristiano, M. J. Lynch, M. Brattain, N. Kim, N. Normanno, N. Kenney, F. Ciardiello, and D. S. Salomon (1991). Regulation by estrogen through the 5′-flanking region of the transforming growth factor α gene. Mol. Endocrinol. 5:1955-1963.
32. S. Noguchi, K. Motomura, H. Inaji, S. Imaoka, and H. Koyama (1993). Down-regulation of transforming growth factor-α by tamoxifen in human breast cancer. Cancer 40:1428-1432.
33. H. Gregory, C. E. Thomas, T. R. Willshire, J. A. Young, H. Andersson, A. Baildam, and A. Howell (1989). Epidermal growth factor and transforming growth factor α in patients with breast tumors. Br. J. Cancer 59:605-609.
34. N. Kenney, T. Saeki, M. Gottardis, N. Kim, P. Garcia-Morales, M. B. Martin, N. Normanno, F. Ciardiello, A. Day, M. L. Cutler, and D. S. Salomon (1993). Expression of transforming growth factor α (TGFα) antisense mRNA inhibits the estrogen-induced production of TGFα and estrogen-induced proliferation of estrogen-responsive human breast cancer cells. J. Cell. Physiol. 156:497-514.
35. V. Shankar, F. Ciardiello, N. Kim, R. Derynck, D. S. Liscia, G. Merlo, B. Langton, D. Sheer, R. Callahan, R. Bassin, M. E. Lippman, N. E. Hynes, and D. S. Salomon (1989). Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA. Mol. Carcin. 2:1-11.
36. Y. Matsui, S. Halter, J. T. Holt, B. L. M. Hogan, and R. J. Coffey (1990). Development of mammary hyperplasia and neoplasia in MMTV-TGFa transgenic mice. Cell 61:1137-1146.
37. L. F. Amundadottir, M. D. Johnsohn, G. Merlino, G. H. Smith, and R. B. Dickson (1995). Synergistic interaction of transforming growth factor α and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Diff. 6:737-748.
38. P. A. Murray, P. J. Barrett-Lee, M. T. Travers, Y. Luqmani, T. Powles, and R. C. Coombes (1993). The prognostic significance of transforming growth factors in breast cancer. Br. J. Cancer 67:1408-1412.
39. F. Ciardiello, N. Kim, D. S. Liscia, C. Bianco, R. Lidereau, G. Merlo, R. Callahan, J. Greiner, C. Szpak, W. Kidwell, J. Schlom, and D. S. Salomon (1989). Transforming growth factor α (TGFα) mRNA expression in human breast carcinomas and TGFa activity in the effusions of breast cancer patients. J. Natl. Cancer Inst. 81:1165-1171.
40. E. A. Dublin, D. M. Barnes, D. Y. Wang, R. J. B. King, and D. A. Levison (1993). TGF alpha and TGF beta expression in mammary carcinoma. J. Pathol. 170:15-22.
41. C. Qi, D. S. Liscia, N. Normanno, G. Merlo, G. R. Johnson, W. J. Gullick, F. Ciardiello, R. Brandt, N. Kim, N. Kenney, and D. S. Salomon (1994). Expression of transforming growth factor α, amphiregulin, and cripto-1 in human breast carcinomas. Br. J. Cancer 69:19896-16901.
42. L. Panico, A. D'Antonio, G. Salvatore, E. Mezza, G. Tortora, M. De Laurentiis, S. De Placido, T. Giordano, M. Merino, D. S. Salomon, W. J. Gullick, G. Pettinato, S. J. Schnitt, A. R. Bianco, and F. Ciardiello (1996). Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissue. Int. J. Cancer 65:51-56.
43. D. H. Parkam and J. Jankowski (1992). Transforming growth factor α in epithelial proliferative diseases of the breast. J. Clin. Pathol. 45:513-516.
44. J. Lundy, A. Scuss, D. Stanick, E. S. McCormack, S. Kramer, and J. M. Sorvillo (1991). Expression of neu protein, EGF and TGFα in breast cancer. Am. J. Pathol. 138:1527-1534.
45. C. L. Arteaga, A. R. Hanauske, G. M. Clark, C. K. Osborne, P. Hazarika, R. L. Pardue, F. Tio, and D. D. Von Hoff (1988). Immunoreactive α transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patients prognosis. Cancer Res. 48:5023-5028.
46. G. D. Plowman, J. M. Green, V. L. McDonald, M. G. Neubauer, C. M. Disteche, G. J. Todaro, and M. Shoyab (1990). The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol. Cell. Biol. 10:1969-1981.
47. I. Martinez-Lacaci, M. Saceda, G. D. Plowman, G. R. Johnson, N. Normanno, D. S. Salomon, and R. B. Dickson (1995). Estrogen and phorbol esters regulate AR expression by two separate mechanisms in human breast cancer cell lines. Endocrinol. 136:3983-3992.
48. N. Kenney, G. H. Smith, I. G. Maroulakou, J. H. Green, W. J. Muller, R. Callahan, D. S. Salomon, and R. B. Dickson (1996). Detection of amphiregulin and cripto-1 in mammary tumors from transgenic mice. Mol. Carcin. 15:44-56.
49. S. LeJeune, R. Leek, E. Horak, G. D. Plowman, M. Greenall, and A. L. Harris (1993). Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer. Cancer Res. 53:3597-3602.
50. E. A. Dublin, L. G. Bobrow, D. M. Barnes, and W. J. Gullick (1995). Amphiregulin and cripto overexpression in breast cancer: relationship with prognosis and clinical and molecular variables. Int. J. Oncol. 7:617-622.
51. E. Peles, S. S. Bacus, R. A. Koski, H. S. Lu, D. Wen, S. G. Ogden, R. B. Levy, and Y. Yarden (1992). Isolation of the neul HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell 69:205-216.
52. S. S. Bacus, A. V. Gudkov, C. R. Zelnic, D. Chin, R. Stern, I. Stancovski, E. Peles, N. Ben-Baruch, H. Farbstein, R. Lupu, D. Wen, M. Sela, and Y. Yarden (1993). Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. Cancer Res. 53:5251-5261.
53. R. J. Pietras, J. Arboleda, D. M. Reese, N. Wongvipat, M. D. Pegram, L. Ramos, C. M. Gorman, M. G. Parker, M. X. Sliwkowski, and D. J. Slamon (1995). HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10:2435-2447.
54. I. M. Krane and P. Leder (1996). NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Oncogene 12:1781-1788.
55. A. Ciccodicola, R. Dono, S. Obici, A. Simeone, M. Zollo, and M. G. Persico (1989). Molecular characterization of a gene of the EGF family expressed in undifferentiated human NTERA2 embryonal carcinoma cells. EMBO J. 8:1987-1991.
56. F. Ciardiello, N. Kim, T. Saeki, R. Dono, M. G. Persico, G. D. Plowman, J. Garrigues, S. Redke, G. J. Todaro, and D. S. Salomon (1991). Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc. Natl. Acad. Sci. U.S.A. 88:7792-7796.
57. F. Ciardiello, G. Tortora, C. Bianco, M. P. Selvam, F. Basolo, G. Fontanini, F. Pacifico, N. Normanno, R. Brandt, M. G. Persico, D. S. Salomon, and A. R. Bianco (1994). Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. Oncogene 9:291-298.
58. F. Ciardiello, R. Dono, N. Kim, M. G. Persico, and D. S. Salomon (1991). Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line. Cancer Res. 51:1051-1054.
59. R. Brandt, N. Normanno, W. J. Gullick, J. H. Lin, R. Harkins, D. Schneider, B. W. Jones, F. Ciardiello, M. G. Persico, F. Amenante, N. Kim, and D. S. Salomon (1994). Identification and biological characterization of an epidermal growth factor-related protein: cripto-1. J. Biol. Chem. 269:17320-17328.
60. N. Normanno, C. Bianco, V. Damiano, E. de Angelis, M. P. Selvam, M. Grassi, G. Magliulo, G. Tortora, A. R. Bianco, J. Mendelsohn, D. S. Salomon, and F. Ciardiello (1996). Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides. Clinical Cancer Res. 2:601-609.